Article
Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification.
Journal of molecular neuroscience : MN - 5 Feb 2024
Zhang Kun, Yang Tianrui, Xia Yu, Guo Xiaopeng, Chen Wenlin, Wang Lijun, Li Junlin, Wu Jiaming, Xiao Zhiyuan, Zhang Xin, Jiang Wenwen, Xu Dongrui, Guo Siying, Wang Yaning, Shi Yixin, Liu Delin, Li Yilin, Wang Yuekun, Xing Hao, Liang Tingyu, Niu Pei, Wang Hai, Liu Qianshu, Jin Shanmu, Qu Tian, Li Huanzhang, Zhang Yi, Ma Wenbin, Wang Yu
Abstract excerpt
Cognitive impairment is a common feature among patients with diffuse glioma. The objective of the study is to investigate the relationship between preoperative cognitive function and clinical as well as molecular factors, firstly based on the new 2021 World Health Organization's updated classification of central nervous system tumors. A total of 110 diffuse glioma patients enrolled underwent preoperative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
